Page 1 | Search Results | Blood | American Society of Hematology

1-17 of 17

Sort by

Sort Order Select

Journal Articles

Patient Characteristics and Treatment Outcomes of TP53 Mutated Myeloid Neoplasms : A Single Cancer Center Experience from the MENA Region

Kamal Al-Rabi, Mohammad Ma'Koseh, Tamer Al-Batsh, Karim Al Sawalha, Anas Zayed, Abeer Yaseen, Yazan Talab Ahmad, Khalid Halahleh, Waleed Kamel Da'Na, Lina Marei, Farid Barakat, Osama Alsmadi, Zaid Abdel Rahman, Omar Ahmad Shahin, Hikmat Abdel-Razeq

Blood (2024) 144 (Supplement 1): 6717.

https://doi.org/10.1182/blood-2024-209335

Published: 2024

Journal Articles

Dose-Adjusted EPOCH-R Is Superior to R-CHOP in Frontline Treatment of Mediastinal Large B-Cell Lymphoma

Mohammad Ma'koseh, Abeer Yaseen, Nebras Abu Abed, Omar Ahmad Shahin, Alaa Abufara, Khalid Halahleh, Mohammad Al-Rwashdeh, Zaid Abdel Rahman, Kamal Al-Rabi, Hikmat Abdel-Razeq

Blood (2024) 144 (Supplement 1): 4465.

https://doi.org/10.1182/blood-2024-208323

Published: 2024

Journal Articles

Characteristics and Outcomes of Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma: A 14-Year Experience in a Limited Resource Setting

Abeer Yaseen, Mohammad Ma'koseh, Albatol Alamoush, Anas Zayed, Mona Ribie, Marah Alzubi, Jawad Alrawabdeh, Rozan Alfar, Waleed Kamel Da'Na, Salwa Shihadeh Saadeh, Yazan Talab, Husam Abu Jazar, Samer Al-Hadidi, Sameer Yaser, Zaid Abdel Rahman

Blood (2024) 144 (Supplement 1): 2277.

https://doi.org/10.1182/blood-2024-205094

Published: 2024

Journal Articles

Genetic Profiling and Risk Stratification of Acute Myeloid Leukemia (AML): Comparative Analysis of the Jordanian AML Cohort (JAMLC) to the German-Austrian AML Study Group (AMLSG)

Zaid Abdel Rahman, Abeer Yaseen, Albatol Alamoush, Lamya Abu Shanab, Teeba Mubaydeen, Rnad Khader, Ahmad Alyamani, Rand Al-Hadaddin, Sulaiman Sayaydeh, Omar Ahmad Shahin, Waleed Kamel Da'Na, Lina Marei, Kamal Alrabi, Yazan Talab, Mohammad Makoseh

Blood (2024) 144 (Supplement 1): 3797.

https://doi.org/10.1182/blood-2024-206057

Published: 2024

Journal Articles

Evaluation of Risk Assessment Models for Predicting Venous Thromboembolic Events in Cancer Patients Using Implanted Central Venous Access Devices

Mohammad Ma'koseh, Heba Farfoura, Mahmoud Abunasser, Maryam El-Atrash, Anas Zayed, Zaid Abdel Rahman, Renad Hamdan-Mansour, Mohammed J Al-Jaghbeer, Hikmat Abdel-Razeq

Blood (2024) 144 (Supplement 1): 1260.

https://doi.org/10.1182/blood-2024-206967

Published: 2024

Journal Articles

A Multicenter Analysis of Allogeneic Transplant Outcomes in Patients with Philadelphia-like (Ph-like) Acute Lymphoblastic Leukemia (ALL)

Blood (2023) 142 (Supplement 1): 656.

https://doi.org/10.1182/blood-2023-178150

Published: 2023

Journal Articles

Prevalence of Vitamin C Deficiency and Bleeding at a Tertiary Care Center: Mayo Clinic Florida (MCF) Experience

ErinMarie O. Kimbrough, Ariana Mooradian, Michael G. Heckman, Zhongwei Peng, Emily B. Butts, Denise A. Gococo-Benore, Zaid Abdel Rahman, Ewa Wysokinska, Gretchen Schaef Johns, James M. Foran

Blood (2022) 140 (Supplement 1): 1420–1421.

https://doi.org/10.1182/blood-2022-170199

Published: 2022

Journal Articles

Epidemiologic and Clinical Analysis of Tumor Mutational Burden (TMB) in Acute Myeloid Leukemia (AML): Exome Sequencing Study of the Mayo Clinic AML Epidemiology Cohort (MCAEC)

James M. Foran, Michael G. Heckman, Yesesri Cherukuri, Mikolaj Wieczorek, Zaid Abdel Rahman, Liuyan Jiang, Hemant S. Murthy, Laura Finn, Talha Badar, Lisa Z. Sproat, Yanyan Lou, James R. Cerhan, Yan Asmann

Blood (2021) 138 (Supplement 1): 3437.

https://doi.org/10.1182/blood-2021-151233

Published: 2021

Journal Articles

Unique Characteristics and Outcomes of Therapy-Related Acute Lymphoblastic Leukemia (trALL) Following Therapy for Multiple Myeloma (MM)

Ricardo D Parrondo, Zaid Abdel Rahman, Michael G. Heckman, Mikolaj Wieczorek, Liuyan Jiang, Hassan B. Alkhateeb, Mark R. Litzow, Patricia Greipp, Taimur Sher, Leif Bergsagel, Rafael Fonseca, Vivek Roy, Angela Dispenzieri, Mohamed A. Kharfan-Dabaja, Hemant S. Murthy, Sikander Ailawadhi, James M. Foran

Blood (2021) 138 (Supplement 1): 2285.

https://doi.org/10.1182/blood-2021-151574

Published: 2021

Journal Articles

Molecular Epidemiology of AML: Association of Somatic Gene Mutations with Epidemiologic Exposures and Outcomes in the Mayo Clinic AML Epidemiology Cohort

Zaid Abdel Rahman, MD, Yesesri Cherukuri, Michael G. Heckman, Laura E. Finn, MD, Liuyan Jiang, MD, Lisa Z. Sproat, MD, James R. Cerhan, MD PhD, Yan Asmann, PhD, James M. Foran, MD

Blood (2020) 136 (Supplement 1): 35–36.

https://doi.org/10.1182/blood-2020-134353

Published: 2020

Journal Articles

Gilteritinib Remains Clinically Active in Relapsed/Refractory FLT3 Mutated AML Previously Treated with FLT3 inhibitors

Yazan Numan, MD, Zaid Abdel Rahman, MD, Justin Grenet, MD, Stephanie Boisclair, MD, Jan Philipp Bewersdorf, MD, Dylan Barth, PharmD, BCPS, Amer M. Zeidan, MBBS, MHS, Musa Yilmaz, MD, Shira Dinner, MD, Yehuda E. Deutsch, MD, Olga Frankfurt, MD, Mark Litzow, MD, Aref Al-Kali, MD, James M. Foran, MD, Lisa Z. Sproat, MD, Borko Jovanovic, PhD, Naval Daver, MD, Alexander E. Perl, MD, Jessica K. Altman, MD

Blood (2020) 136 (Supplement 1): 5–7.

https://doi.org/10.1182/blood-2020-137251

Published: 2020

Journal Articles

Identification of Targetable Tumor Associated Proteins in Adult T-Acute Lymphoblastic Leukemia/Lymphoma (T-ALL/LBL) Including a Novel CC-Chemokine 4 (CCR4)-Positive T-ALL/LBL with Unique Immunophenotype

Sharad Khurana, MDMSc, Michael G. Heckman, Jordan Cochuyt, Fiona E. Craig, MBBS, Zaid Abdel Rahman, MD, Patricia Greipp, DO, Lisa Z. Sproat, MD, Mark Litzow, MD, James M. Foran, MD, Liuyan Jiang

Blood (2019) 134 (Supplement_1): 5210.

https://doi.org/10.1182/blood-2019-123286

Published: 2019

Journal Articles

Baseline Hypoalbuminemia Does Not Appear to be an Adverse Prognostic Factor in Patients with Relapse/Refractory B-Cell Lymphomas Treated with Axicabtagene Ciloleucel (axi-cel)

Blood (2019) 134 (Supplement_1): 5343.

https://doi.org/10.1182/blood-2019-126594

Published: 2019

Journal Articles

Impact of Anti-CD19 CAR-T Axicabtagene Ciloleucel on Vaccine Titers of DTaP and MMR

Zaid Abdel Rahman, MD, Nicole Gannon, PA-C, Megan Melody, MD, Paul Muniz, RN, Ernesto Ayala, MD, Vivek Roy, MD, Lisa Brumble, Sikander Ailawadhi, MD, Taimur Sher, MD, James M. Foran, MD, Hemant S. Murthy, MD, Han W. Tun, MD, Candido E. Rivera, MD, Asher A. Chanan-Khan, MD, Abba C. Zubair, MD PhD, Mohamed A Kharfan-Dabaja, MDMBA

Blood (2019) 134 (Supplement_1): 5610.

https://doi.org/10.1182/blood-2019-122067

Published: 2019

Journal Articles

Impact of Targeted Immunotherapies and Novel Cytogenetic and Clinical Risk Groups on Outcome after Allogeneic Hematopoietic Stem Cell Transplant (AlloHCT) for Acute Lymphoblastic Leukemia (ALL): The Mayo Clinic Cohort

Zaid Abdel Rahman, MD, Michael G. Heckman, Kevin C. Miller, BS, Patricia Greipp, DO, Matthew R Spiegel, Sharad Khurana, MDMSc, Hassan B. Alkhateeb, MD, Mrinal M Patnaik, MDMBBS, Lisa Z. Sproat, MD, Liuyan Jiang, Vivek Roy, MD, Mark Litzow, MD, Mohamed A Kharfan-Dabaja, MDMBA, William J Hogan, MB, BCh, James M. Foran, MD

Blood (2019) 134 (Supplement_1): 2588.

https://doi.org/10.1182/blood-2019-122068

Published: 2019

Journal Articles

Plasmapheresis and Myeloma Cast Nephropathy: A Meta-Analysis and Review of Evidence

Yaser Alkhatib, Aliakbar Dadla, MD, Devin Malik, MD, Zaid Abdel-Rahman, MD, Philip Kuriakose, MD, Vrushali S. Dabak, MD, Vijayalakshmi Donthireddy

Blood (2017) 130 (Supplement 1): 5415.

https://doi.org/10.1182/blood.V130.Suppl_1.5415.5415

Published: 2017

Journal Articles

Hematology Referrals for Mild Thrombocytopenia in a Tertiary Center in Detroit: A Step Towards a Standardized Approach for Referrals and Testing

Zaid Abdel-Rahman, MD, Kutayba Alsafadi, MD, Hiba Jabbour, MD, Vivek Mendiratta, MD, Yaser Alkhatib, Vijaya Donthireddy, MD

Blood (2017) 130 (Supplement 1): 4655.

https://doi.org/10.1182/blood.V130.Suppl_1.4655.4655

Published: 2017

NARROW

Patient Characteristics and Treatment Outcomes of TP53 Mutated Myeloid Neoplasms : A Single Cancer Center Experience from the MENA Region

Dose-Adjusted EPOCH-R Is Superior to R-CHOP in Frontline Treatment of Mediastinal Large B-Cell Lymphoma

Characteristics and Outcomes of Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma: A 14-Year Experience in a Limited Resource Setting

Genetic Profiling and Risk Stratification of Acute Myeloid Leukemia (AML): Comparative Analysis of the Jordanian AML Cohort (JAMLC) to the German-Austrian AML Study Group (AMLSG)

Evaluation of Risk Assessment Models for Predicting Venous Thromboembolic Events in Cancer Patients Using Implanted Central Venous Access Devices

A Multicenter Analysis of Allogeneic Transplant Outcomes in Patients with Philadelphia-like (Ph-like) Acute Lymphoblastic Leukemia (ALL)

Prevalence of Vitamin C Deficiency and Bleeding at a Tertiary Care Center: Mayo Clinic Florida (MCF) Experience

Epidemiologic and Clinical Analysis of Tumor Mutational Burden (TMB) in Acute Myeloid Leukemia (AML): Exome Sequencing Study of the Mayo Clinic AML Epidemiology Cohort (MCAEC)

Unique Characteristics and Outcomes of Therapy-Related Acute Lymphoblastic Leukemia (trALL) Following Therapy for Multiple Myeloma (MM)

Molecular Epidemiology of AML: Association of Somatic Gene Mutations with Epidemiologic Exposures and Outcomes in the Mayo Clinic AML Epidemiology Cohort

Gilteritinib Remains Clinically Active in Relapsed/Refractory FLT3 Mutated AML Previously Treated with FLT3 inhibitors

Identification of Targetable Tumor Associated Proteins in Adult T-Acute Lymphoblastic Leukemia/Lymphoma (T-ALL/LBL) Including a Novel CC-Chemokine 4 (CCR4)-Positive T-ALL/LBL with Unique Immunophenotype

Baseline Hypoalbuminemia Does Not Appear to be an Adverse Prognostic Factor in Patients with Relapse/Refractory B-Cell Lymphomas Treated with Axicabtagene Ciloleucel (axi-cel)

Impact of Anti-CD19 CAR-T Axicabtagene Ciloleucel on Vaccine Titers of DTaP and MMR

Impact of Targeted Immunotherapies and Novel Cytogenetic and Clinical Risk Groups on Outcome after Allogeneic Hematopoietic Stem Cell Transplant (AlloHCT) for Acute Lymphoblastic Leukemia (ALL): The Mayo Clinic Cohort

Plasmapheresis and Myeloma Cast Nephropathy: A Meta-Analysis and Review of Evidence

Hematology Referrals for Mild Thrombocytopenia in a Tertiary Center in Detroit: A Step Towards a Standardized Approach for Referrals and Testing

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only